Healthlead PCL (BKK: HL)
Thailand
· Delayed Price · Currency is THB
8.70
-0.05 (-0.57%)
Nov 22, 2024, 4:36 PM ICT
Healthlead PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Operating Revenue | 1,800 | 1,636 | 1,520 | 1,199 | 1,064 | 925.94 | Upgrade
|
Other Revenue | 33.67 | 23.77 | 18.69 | 17.62 | 15.91 | 9.03 | Upgrade
|
Revenue | 1,834 | 1,659 | 1,538 | 1,216 | 1,080 | 934.97 | Upgrade
|
Revenue Growth (YoY) | 15.34% | 7.87% | 26.46% | 12.63% | 15.51% | 18.18% | Upgrade
|
Cost of Revenue | 1,384 | 1,258 | 1,143 | 922.42 | 831.18 | - | Upgrade
|
Gross Profit | 450.13 | 400.98 | 394.95 | 293.95 | 248.81 | 934.97 | Upgrade
|
Selling, General & Admin | 355.55 | 306.94 | 249.52 | 191.31 | 175.4 | 902.68 | Upgrade
|
Other Operating Expenses | -6.16 | -6.68 | -2.97 | - | - | - | Upgrade
|
Operating Expenses | 349.39 | 300.26 | 246.55 | 191.31 | 175.4 | 902.68 | Upgrade
|
Operating Income | 100.74 | 100.72 | 148.39 | 102.64 | 73.41 | 32.3 | Upgrade
|
Interest Expense | -10.9 | -8.98 | -5.73 | -5.34 | -6.99 | -3.79 | Upgrade
|
Interest & Investment Income | 6.8 | 2.87 | 0.17 | 0.04 | 0.11 | 0.22 | Upgrade
|
EBT Excluding Unusual Items | 96.81 | 94.61 | 142.83 | 97.35 | 66.54 | 28.73 | Upgrade
|
Asset Writedown | -0.57 | -0.57 | - | - | - | - | Upgrade
|
Pretax Income | 96.24 | 94.04 | 142.83 | 97.35 | 66.54 | 28.73 | Upgrade
|
Income Tax Expense | 20.03 | 19.36 | 24.61 | 17.68 | 14.46 | 6.96 | Upgrade
|
Net Income | 76.21 | 74.68 | 118.23 | 79.66 | 52.08 | 21.77 | Upgrade
|
Net Income to Common | 76.21 | 74.68 | 118.23 | 79.66 | 52.08 | 21.77 | Upgrade
|
Net Income Growth | -18.91% | -36.84% | 48.41% | 52.98% | 139.25% | 5489.69% | Upgrade
|
Shares Outstanding (Basic) | 272 | 272 | 272 | 206 | 162 | 160 | Upgrade
|
Shares Outstanding (Diluted) | 272 | 272 | 272 | 206 | 162 | 160 | Upgrade
|
Shares Change (YoY) | - | - | 31.84% | 27.46% | 1.16% | - | Upgrade
|
EPS (Basic) | 0.28 | 0.27 | 0.43 | 0.39 | 0.32 | 0.14 | Upgrade
|
EPS (Diluted) | 0.28 | 0.27 | 0.43 | 0.39 | 0.32 | 0.14 | Upgrade
|
EPS Growth | -18.91% | -36.84% | 12.57% | 20.02% | 136.50% | 5491.41% | Upgrade
|
Free Cash Flow | 30.77 | 9.72 | 16.07 | 72.44 | 83.56 | - | Upgrade
|
Free Cash Flow Per Share | 0.11 | 0.04 | 0.06 | 0.35 | 0.52 | - | Upgrade
|
Dividend Per Share | 0.150 | 0.150 | 0.180 | 0.280 | 0.070 | - | Upgrade
|
Dividend Growth | -16.67% | -16.67% | -35.71% | 300.00% | - | - | Upgrade
|
Gross Margin | 24.54% | 24.17% | 25.68% | 24.17% | 23.04% | 100.00% | Upgrade
|
Operating Margin | 5.49% | 6.07% | 9.65% | 8.44% | 6.80% | 3.45% | Upgrade
|
Profit Margin | 4.16% | 4.50% | 7.69% | 6.55% | 4.82% | 2.33% | Upgrade
|
Free Cash Flow Margin | 1.68% | 0.59% | 1.04% | 5.96% | 7.74% | - | Upgrade
|
EBITDA | 135.85 | 126.32 | 162.96 | 117.12 | 80.15 | 47.36 | Upgrade
|
EBITDA Margin | 7.41% | 7.61% | 10.59% | 9.63% | 7.42% | 5.07% | Upgrade
|
D&A For EBITDA | 35.11 | 25.6 | 14.57 | 14.48 | 6.74 | 15.06 | Upgrade
|
EBIT | 100.74 | 100.72 | 148.39 | 102.64 | 73.41 | 32.3 | Upgrade
|
EBIT Margin | 5.49% | 6.07% | 9.65% | 8.44% | 6.80% | 3.45% | Upgrade
|
Effective Tax Rate | 20.81% | 20.58% | 17.23% | 18.16% | 21.73% | 24.23% | Upgrade
|
Revenue as Reported | 1,834 | 1,659 | 1,538 | 1,216 | 1,080 | 935.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.